Table 2. Adverse events.
| Grade | Total | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 5 | ||
| Anorexia | 4 | 8 | 12 | ||
| Leukocytopenia | 1 | 1 | 2 | ||
| Weight loss | 2 | 2 | |||
| Nausea | 2 | 2 | |||
| Decreases in Hb level | 1 | 1 | |||
| Anemia | 2 | 2 | |||
| Urticaria (hives, welts, wheals) | 1 | 1 | |||
| Liver dysfunction/failure (clinical) | 2 | 2 | |||
| Allergic reactions/hypersensitivity | 1 | 1 | |||
| Diarrhea | 1 | 1 | |||
| Pancreatitis* | 1 | 1 | |||
| Fever* | 2 | 1 | 3 | ||
| Rash* | 1 | 1 | |||
| Infection-Others** (Intraabdominal abcess) | 1 | 1 | |||
| Suicide attempt*** | 1 | 1 | |||
* immunotherapy and/or EUS-FNI-related adverse events
** EUS-FNI-related adverse event
*** Non-immunotherapy and EUS-FNI-related adverse event